Therapy of corneal endothelial dysfunction with corneal endothelial cell-like cells derived from skin-derived precursors
- PMID: 29042661
- PMCID: PMC5645363
- DOI: 10.1038/s41598-017-13787-1
Therapy of corneal endothelial dysfunction with corneal endothelial cell-like cells derived from skin-derived precursors
Abstract
Corneal endothelial dysfunction occurs when corneal endothelial cells (CECs) are dramatically lost and eventually results in vision loss. Corneal transplantation is the only solution at present. However, corneal transplantation requires a fresh human cornea and there is a worldwide shortage of donors. Therefore, finding new functional CECs to replace human CECs is urgent. Skin-derived precursors (SKPs) can be easily acquired and have multiple differential potential. We co-cultured human SKPs with B4G12 cells in serum-free medium and obtained abundant CEC-like cells which had similar morphology and characteristic to human CECs. CEC-like cells exerted excellent therapeutic effect when they were transplanted into rabbit and monkey corneal endothelial dysfunction models by injection method. This protocol enables efficient production of CEC-like cells from SKPs. The renewable cell source, novel derivation method and simple treatment strategy may lead to potential applications in cell replacement therapy for corneal endothelial dysfunction.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures







Similar articles
-
Skin-Derived Precursors as a Source of Progenitors for Corneal Endothelial Regeneration.Stem Cells Transl Med. 2017 Mar;6(3):788-798. doi: 10.1002/sctm.16-0162. Epub 2017 Feb 6. Stem Cells Transl Med. 2017. PMID: 28186681 Free PMC article.
-
Long-Term Observation and Sequencing Analysis of SKPs-Derived Corneal Endothelial Cell-Like Cells for Treating Corneal Endothelial Dysfunction.Cell Transplant. 2021 Jan-Dec;30:9636897211017830. doi: 10.1177/09636897211017830. Cell Transplant. 2021. PMID: 34053246 Free PMC article.
-
Promoting the expansion and function of human corneal endothelial cells with an orbital adipose-derived stem cell-conditioned medium.Stem Cell Res Ther. 2017 Dec 20;8(1):287. doi: 10.1186/s13287-017-0737-5. Stem Cell Res Ther. 2017. PMID: 29262856 Free PMC article.
-
Challenges in corneal endothelial cell culture.Regen Med. 2021 Sep;16(9):871-891. doi: 10.2217/rme-2020-0202. Epub 2021 Aug 12. Regen Med. 2021. PMID: 34380324 Free PMC article. Review.
-
Corneal Endothelial-like Cells Derived from Induced Pluripotent Stem Cells for Cell Therapy.Int J Mol Sci. 2023 Aug 4;24(15):12433. doi: 10.3390/ijms241512433. Int J Mol Sci. 2023. PMID: 37569804 Free PMC article. Review.
Cited by
-
Adipose Mesenchymal Stem Cell-Derived Exosomes Promote the Regeneration of Corneal Endothelium Through Ameliorating Senescence.Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):29. doi: 10.1167/iovs.64.13.29. Invest Ophthalmol Vis Sci. 2023. PMID: 37850944 Free PMC article.
-
Focus on seed cells: stem cells in 3D bioprinting of corneal grafts.Front Bioeng Biotechnol. 2024 Jul 10;12:1423864. doi: 10.3389/fbioe.2024.1423864. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39050685 Free PMC article. Review.
-
The Human Skin-Derived Precursors for Regenerative Medicine: Current State, Challenges, and Perspectives.Stem Cells Int. 2018 Jul 11;2018:8637812. doi: 10.1155/2018/8637812. eCollection 2018. Stem Cells Int. 2018. PMID: 30123295 Free PMC article. Review.
-
Mesenchymal Stem Cells and Exosomes: A Novel Therapeutic Approach for Corneal Diseases.Int J Mol Sci. 2023 Jun 30;24(13):10917. doi: 10.3390/ijms241310917. Int J Mol Sci. 2023. PMID: 37446091 Free PMC article. Review.
-
Biomedical Application of MSCs in Corneal Regeneration and Repair.Int J Mol Sci. 2025 Jan 15;26(2):695. doi: 10.3390/ijms26020695. Int J Mol Sci. 2025. PMID: 39859409 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical